ReviewNature reviews. Rheumatology2013
Differential diagnosis and management of Behçet syndrome.
Review in Nature reviews. Rheumatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- The "two flowers therapy": clinical efficacy and mechanisms of a total glucosides of paeony -colchicine dual-drugs for Behçet's disease derived from Chinese physicians' medication experience.Frontiers in immunology · 2026Observational
- Expression of miR-127 and miR-29 in Egyptian patients with Behçet disease and its clinical significance and relationship with disease activity.Clinical rheumatology · 2025Article
- Characterization of potential salivary biomarkers in Behçet's disease.Internal and emergency medicine · 2025Article
- Intramedullary Spinal Hemorrhage in Behcet's Syndrome: A Case Report and Systematic Review.Cureus · 2023Article
- The impact of Behcet syndrome on total knee arthroplasty outcomes: a retrospective matched cohort study.International orthopaedics · 2023Article
- Performance of diagnostic criteria in pediatric Behçet's disease.Rheumatology international · 2022Observational
- Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist.Current dermatology reports · 2022Review
- Antineutrophil Cytoplasmic Antibody Positivity Is Associated with Vascular Involvement in Behçet's Disease.Yonsei medical journal · 2021Article
- Vascular involvement in Behçet's disease: the immunopathological process.Jornal vascular brasileiro · 2021Review
- Pediatric Behçet's Disease.Frontiers in medicine · 2021Review
- Extracellular vesicles as potential biomarkers and therapeutic approaches in autoimmune diseases.Journal of translational medicine · 2020Review
- [Behçet's syndrome : Current diagnostics and treatment].Zeitschrift fur Rheumatologie · 2020Review
- Trends in Hospitalization and Inpatient Outcomes of Behçet's Disease: A Nationwide Inpatient Sample Study.Cureus · 2020Article
- Comparability of European League Against Rheumatology-Recommended Pharmacological Treatments of Oral Ulcers Associated with Behçet's Disease: A Systematic Literature Review of Randomized Controlled Trials.Open access rheumatology : research and reviews · 2020Article
- Demography of vascular Behcet's disease with different gender and age: an investigation with 166 Chinese patients.Orphanet journal of rare diseases · 2019Article
- Behçet Syndrome and Crohn's Disease: What Are the Differences?European journal of case reports in internal medicine · 2019Article
- Serious Coronary Thrombosis and Pulmonary Artery Thrombosis Revealing Behçet's Disease.Archives of rheumatology · 2018Article
- Article
- Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry.International journal of molecular sciences · 2017Article
- Surgical Intervention for Behcet's Disease with Aorta Aneurysm and Pseudoaneurysm: Opposite Outcomes in Two Cases.Chinese medical journal · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Behçet syndrome (also known as Behçet disease) is a rare condition that is associated with considerable morbidity. Cases of Behçet syndrome have been reported worldwide, but the highest prevalence occurs in countries that border the ancient Silk Route, such as Turkey and Iran. Although oral ulceration, genital ulceration and eye disease are the classic triad of manifestations, the cardiovascular, gastrointestinal, musculoskeletal and central nervous systems can also be affected. The syndrome is chronic and relapsing with some patients having benign episodes whereas others have more serious complications, including blindness or the rupture of a pulmonary arterial aneurysm. Diagnosing Behçet syndrome, particularly outside of endemic regions, often incurs a considerable delay owing to the rarity of this condition. Furthermore, a paucity exists of data from randomized controlled trials on the optimal therapeutic approaches to use in patients, as well as a lack of informative laboratory surrogate markers to monitor disease progression. This Review discusses the issues surrounding the diagnosis and differential diagnosis of Behçet syndrome and presents the current approaches to managing patients with this complex group of disorders.
Indexed as
Identifiers
23007742What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.